Representatives from civil society, and national and international stakeholders identify critical areas of concern, from health, advocacy and human rights, and provide recommendations for continuing their work.
Drug-using populations are still facing many challenges, with lack of empathy, inaccessibility of naloxone, and health consequences following non-fatal overdose creating significant barriers to addressing overdose risks.
EECA INTERACT 2022 will bring together scientists, clinicians, members of civil society, and government officials to tackle topics facing individual countries while building capacity and strengthening research and clinical networks.
C-EHRN provides an update on the work to ensure access to harm reduction services and other forms of care and support for populations in situations of vulnerability in Ukraine and neighbouring countries.
Despite success in offering alternatives to prosecution, diversion schemes have become increasingly repressive and harmful, moving away from full decriminalisation.
Students for Sensible Drug Policy International and Youth RISE are launching a new Erasmus+ project intended to increase the capacity of youth-led organisations that engage in drug policy reform and young people to advocate at the European Union level.
The survey's respondents were primarily cannabis growers, who had experiences of self-medication with cannabis, and supported different policies of legalisation and regulation - including age restrictions and licensing requirements to apply for commercial growing.
The EMCDDA highlight that drug use remains high across the EU, with drug consumption patterns becoming increasingly complex and the impacts on health and social responses.
